2021-12-01 | Statin in combination with cisplatin makes favorable tumor-immune microenvironment for immunotherapy of head and neck squamous cell carcinoma | Kwon, Minsu; Nam, Gi-Hoon; Jung, Hanul; Kim, Seong A.; Kim, Seohyun; Choi, Yeonju; Lee, Yoon Se; Cho, Hyo Jung; Kim, In-San |
2021-08 | Anticoagulation therapy promotes the tumor immune-microenvironment and potentiates the efficacy of immunotherapy by alleviating hypoxia | Choi, Jeong Uk; Lee, Na Kyeong; Seo, Hyungseok; Chung, Seung Woo; Al-Hilal, Taslim A.; Park, Seong Jin; Kweon, Seho; Min, Nuri; Kim, Sang Kyoon; Ahn, Seohyun; Kim, Uk-Il; Park, Jin Woo; Kang, Chang-Yuil; Kim, In-San; Kim, Sang Yoon; Kim, Kyungjin; Byun, Youngro |
2021-05 | Cancer-activated doxorubicin prodrug nanoparticles induce preferential immune response with minimal doxorubicin-related toxicity | Yang, Suah; Shim, Man Kyu; Kim, Woo Jun; Choi, Jiwoong; Nam, Gi-Hoon; Kim, Jeongrae; Kim, Jinseong; Moon, Yujeong; Kim, Han Young; Park, Jooho; Park, Yoon; Kim, In-San; Ryu, Ju Hee; Kim, Kwangmeyung |
2021-10 | Caspase-cleavable peptide-doxorubicin conjugate in combination with CD47-antagonizing nanocage therapeutics for immune-mediated elimination of colorectal cancer | Lee, Na Kyeong; Choi, Jeong Uk; Kim, Ha Rin; Chung, Seung Woo; Ko, Yoon Gun; Cho, Young Seok; Park, Seong Jin; Lee, Eun Jung; Kim, Sang Yoon; Kim, In-San; Byun, Youngro |